Care Twentyone Corporation

As of April 30, 2024, Care Twentyone Corporation carries a market capitalization of 7.69B, placing it among publicly traded companies globally. Its enterprise value stands at 24.97B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Care Twentyone Corporation's next confirmed earnings release is scheduled for December 11, 2026.

As of April 30, 2024, Care Twentyone Corporation has 13.50M shares outstanding.

These figures are as of April 30, 2024. The price-to-sales ratio is 0.18, and the price-to-book ratio stands at 1.61.

These figures are as of April 30, 2024. The EV/Sales ratio of 0.58 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 24.97B versus a market cap of 7.69B, with the gap driven by net debt and cash on the balance sheet.

As of April 30, 2024, Care Twentyone Corporation maintains a current ratio of 0.97, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 402.36, indicating elevated leverage, while an interest coverage ratio of -1.15 demonstrates limited ability to service its debt obligations.

Over the twelve months ended April 30, 2024, Care Twentyone Corporation posted a negative return on equity (ROE) of -8.77, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.35, reflecting losses generated across the asset base. The company generates approximately 7.42M in revenue per employee across its workforce of 5,819.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 765.42 indicates how many times Care Twentyone Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended April 30, 2024, Care Twentyone Corporation recorded 193.55M in income tax expense. The company reported a pretax loss of -289.70M and -480.64M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Care Twentyone Corporation's stock has declined approximately 24.50% over the past 52 weeks. The 50-day moving average sits at 421.08, while the 200-day moving average is 422.65.

Over the twelve months ended April 30, 2024, Care Twentyone Corporation generated 43.20B in revenue and converted that into -480.64M in net income, yielding earnings per share of -35.84. EBITDA reached -627.23M, while operating income came in at -627.22M.

As of April 30, 2024, Care Twentyone Corporation holds 2.00B in cash and equivalents against 19.26B in total debt, resulting in a net debt position of 6.80B. Total book value stands at 4.78B, with working capital of -378.96M providing operational flexibility.

Over the twelve months ended April 30, 2024, Care Twentyone Corporation posted a gross margin of 21.32, reflecting its pricing power and cost economics. The operating margin of -1.45 and net profit margin of -1.11 provide insight into operational efficiency.

Care Twentyone Corporation's most recent stock split took place on April 28, 2021 with a 33:100 split ratio.

As of April 30, 2024, Care Twentyone Corporation has an Altman Z-Score of 1.57, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.